http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113730613-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K103-30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00 |
filingDate | 2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113730613-B |
titleOfInvention | Application of lutetium-labeled nano-carrier in preparation of medicine for treating neuroendocrine tumor |
abstract | The invention relates to the technical field of preparation of antitumor drugs, in particular to application of a lutetium-labeled nano-carrier in preparation of a drug for treating neuroendocrine tumors, and provides a preparation method of the lutetium-labeled nano-carrier. Experiment of the invention verifies 177 Lu-SPN-GIP can realize the rapid ablation effect of photothermal therapy on neuroendocrine tumors, retain the DNA double-strand damage effect of nuclides on tumor cells, and simultaneously have the in-vivo tracing function of the nuclides. |
priorityDate | 2021-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 90.